PYY3-36 Causes Taste Aversion at Appetite-Suppressing Doses — A Nausea Concern

PYY3-36 at doses that suppress appetite also produced conditioned taste aversion in mice, suggesting its anorectic effect may partly involve nausea/malaise rather than pure physiological satiety — a caution for obesity drug development.

Halatchev, Ilia G et al.·Cell metabolism·2005·Moderate EvidenceAnimal StudyAnimal Study
RPEP-01042Animal StudyModerate Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Peripheral PYY3-36 at appetite-suppressing doses produced conditioned taste aversion (learned food avoidance suggesting nausea), indicating its anorectic effect may partly involve malaise rather than pure satiety — an important consideration for PYY-based obesity drugs.

Key Numbers

How They Did This

animal-study study on neuropeptides, weight-loss.

Why This Research Matters

Relevant for neuropeptides, weight-loss, receptor-signaling.

The Bigger Picture

Advances peptide research with clinical implications.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Peripheral PYY3-36 at appetite-suppressing doses produced conditioned taste aversion (learned food avoidance suggesting nausea), indicating its anorec
Evidence Grade:
moderate evidence.
Study Age:
Published in 2005.
Original Title:
Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice.
Published In:
Cell metabolism, 1(3), 159-68 (2005)
Database ID:
RPEP-01042

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

PYY3-36 Causes Taste Aversion at Appetite-Suppressing Doses — A Nausea Concern

What was found?

PYY3-36 at doses that suppress appetite also produced conditioned taste aversion in mice, suggesting its anorectic effect may partly involve nausea/malaise rather than pure physiological satiety — a caution for obesity drug development.

Read More on RethinkPeptides

Cite This Study

RPEP-01042·https://rethinkpeptides.com/research/RPEP-01042

APA

Halatchev, Ilia G; Cone, Roger D. (2005). Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice.. Cell metabolism, 1(3), 159-68.

MLA

Halatchev, Ilia G, et al. "Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice.." Cell metabolism, 2005.

RethinkPeptides

RethinkPeptides Research Database. "Peripheral administration of PYY(3-36) produces conditioned ..." RPEP-01042. Retrieved from https://rethinkpeptides.com/research/halatchev-2005-peripheral-administration-of-pyy336

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.